Profile
Full Name
Crescent Biopharma, Inc.Ticker
NASDAQ: CBIOExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
April 12, 2006Indexes
Not includedEmployees
6Key Details
Price
$12.85(+16.82%)
Market cap
$178.52M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-
PE ratio
-
Next earnings date
N/ANext ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Crescent Biopharma, Inc. doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Jul 14, 25 Wedbush
OutperformJun 25, 25 Stifel
BuyNov 15, 21 Raymond James
Market PerformAug 6, 21 Raymond James
OutperformApr 29, 21 Raymond James
OutperformFeb 10, 21 Piper Sandler
OverweightFeb 4, 21 Raymond James
OutperformJan 4, 19 Oppenheimer
OutperformJun 21, 18 B. Riley Securities
NeutralJun 21, 18 B. Riley FBR
NeutralInstitutional Ownership
- What is the ticker symbol for Crescent Biopharma, Inc.?
- Does Crescent Biopharma, Inc. pay dividends?
- What sector is Crescent Biopharma, Inc. in?
- What industry is Crescent Biopharma, Inc. in?
- What country is Crescent Biopharma, Inc. based in?
- When did Crescent Biopharma, Inc. go public?
- Is Crescent Biopharma, Inc. in the S&P 500?
- Is Crescent Biopharma, Inc. in the NASDAQ 100?
- Is Crescent Biopharma, Inc. in the Dow Jones?
- When was Crescent Biopharma, Inc.'s last earnings report?
- When does Crescent Biopharma, Inc. report earnings?
What is the ticker symbol for Crescent Biopharma, Inc.?
The ticker symbol for Crescent Biopharma, Inc. is NASDAQ:CBIO
Does Crescent Biopharma, Inc. pay dividends?
No, Crescent Biopharma, Inc. does not pay dividends
What sector is Crescent Biopharma, Inc. in?
Crescent Biopharma, Inc. is in the Healthcare sector
What industry is Crescent Biopharma, Inc. in?
Crescent Biopharma, Inc. is in the Biotechnology industry
What country is Crescent Biopharma, Inc. based in?
Crescent Biopharma, Inc. is headquartered in United States
When did Crescent Biopharma, Inc. go public?
Crescent Biopharma, Inc.'s initial public offering (IPO) was on April 12, 2006
Is Crescent Biopharma, Inc. in the S&P 500?
No, Crescent Biopharma, Inc. is not included in the S&P 500 index
Is Crescent Biopharma, Inc. in the NASDAQ 100?
No, Crescent Biopharma, Inc. is not included in the NASDAQ 100 index
Is Crescent Biopharma, Inc. in the Dow Jones?
No, Crescent Biopharma, Inc. is not included in the Dow Jones index
When was Crescent Biopharma, Inc.'s last earnings report?
Crescent Biopharma, Inc.'s most recent earnings report was on August 2, 2018
When does Crescent Biopharma, Inc. report earnings?
The date for Crescent Biopharma, Inc.'s next earnings report has not been announced yet